Article Information
PubMed
Print ISSN
Online ISSN
History
- Published online September 12, 2006.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Akhlaq A. Farooqui,
- Wei-Yi Ong, and
- Lloyd A. Horrocks
- Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio (A.A.F., L.A.H.); and Department of Anatomy, National University of Singapore, Singapore, Singapore (W.-Y.O.)
- Address correspondence to: Dr. Lloyd A. Horrocks, Department of Molecular and Cellular Biochemistry, 1645 Neil Ave., The Ohio State University, Columbus, OH 43210-1218. E-mail: horrocks.2{at}osu.edu
Statistics from Altmetric.com
Article usage
In this issue
Inhibitors of Brain Phospholipase A2 Activity: Their Neuropharmacological Effects and Therapeutic Importance for the Treatment of Neurologic Disorders
Jump to section
- Article
- Abstract
- I. Introduction
- II. Multiplicity of Phospholipases A2 in Brain
- III. Involvement of Phospholipase A2 Activity in Brain Injury
- IV. Physiological and Pharmacological Effects of Phospholipase A2 Inhibitors
- V. Phospholipase A2 Activity in Kainic Acid-Induced Neural Cell Injury
- VI. Protection of Kainic Acid-Induced Neural Cell Injury by Phospholipase A2 Inhibitors
- VII. Phospholipase A2 Activity in Neurological Disorders
- VIII. Use of Phospholipase A2 Inhibitors for the Treatment of Neurological Disorders
- IX. Prevention of Pain by Phospholipase A2 Inhibitors
- X. Perspective and Direction for Future Studies
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics
- eLetters
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement